TriSalus Life Sciences Inc. (TLSI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
270,312,000
EV to revenue ratio (TTM)
6.57
EV to ebitda
-5.96
Financial Performance
Revenue (TTM)
45,077,000
Gross profit (TTM)
38,671,000
EBITDA
-29,949,000
Profitability
Operating margin (TTM)
-86.00%
Profit margin
-62.60%
Return on assets (TTM)
-36.70%
Return on equity (TTM)
-496.20%
Per Share Metrics
Revenue per share (TTM)
0.9
EPS
-1.35
Diluted EPS (TTM)
-1.35
Book value
0.11
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
6
Price to book ratio (TTM)
47
Growth
Quarterly earnings growth (YoY)
1.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.438